AXIM Biotechnologies, Inc. (AXIM) stock
AXIMOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2024, quý kết thúc ngày Jun 30, 2024Last filing: 10-Q on Aug 19, 2024
$0.00+0.00 (+2.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
AXIM Biotechnologies operating margin
Operating margin is operating income as a percentage of revenue.
AXIM Biotechnologies's operating margin for the twelve months ending Jun 30, 2024 was -2490.3%. For fiscal 2023 it was -6961.0%, against -52425.6% the year before. The highest annual figure on record is -388.9% in fiscal 2019.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -6961.0% | +45464.6 |
| FY2022 | Dec 31, 2022 | -52425.6% | −29311.1 |
| FY2021 | Dec 31, 2021 | -23114.5% | −22725.6 |
| FY2019 | Dec 31, 2019 | -388.9% | +2185.7 |
| FY2018 | Dec 31, 2018 | -2574.5% | +4045.0 |
| FY2017 | Dec 31, 2017 | -6619.5% | +1369.3 |
| FY2016 | Dec 31, 2016 | -7988.8% | +12462.4 |
| FY2015 | Dec 31, 2015 | -20451.3% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2024 | Jun 30, 2024 | -3257.9% | +3769.3 |
| Q1 FY2024 | Mar 31, 2024 | -758.0% | +8849.1 |
| Q4 FY2023 | Dec 31, 2023 | -5863.1% | +9245.5 |
| Q3 FY2023 | Sep 30, 2023 | -6142.7% | +94155.6 |
| Q2 FY2023 | Jun 30, 2023 | -7027.2% | +151997.6 |
| Q1 FY2023 | Mar 31, 2023 | -9607.1% | +30733.2 |
| Q4 FY2022 | Dec 31, 2022 | -15108.6% | −446.2 |
| Q3 FY2022 | Sep 30, 2022 | -100298.3% | −97639.7 |
| Q4 FY2021 | Dec 31, 2021 | -159024.8% | −158953.7 |
| Q3 FY2021 | Sep 30, 2021 | -40340.3% | −26896.4 |
| Q2 FY2021 | Jun 30, 2021 | -14662.4% | −14229.4 |
| Q1 FY2021 | Mar 31, 2021 | -2658.6% | +12377.2 |
| Q4 FY2019 | Dec 31, 2019 | -71.1% | +16334.6 |
| Q1 FY2019 | Mar 31, 2019 | -13443.9% | +847.2 |
| Q4 FY2018 | Dec 31, 2018 | -433.1% | +6363.0 |
| Q3 FY2018 | Sep 30, 2018 | -15035.8% | −2891.4 |
| Q2 FY2018 | Jun 30, 2018 | -16405.7% | −4708.3 |
| Q1 FY2018 | Mar 31, 2018 | -14291.1% | −11733.0 |
| Q4 FY2017 | Dec 31, 2017 | -6796.1% | −489.5 |
| Q3 FY2017 | Sep 30, 2017 | -12144.4% | +4059.5 |
| Q2 FY2017 | Jun 30, 2017 | -11697.4% | −7325.2 |
| Q1 FY2017 | Mar 31, 2017 | -2558.1% | +4169.3 |
| Q4 FY2016 | Dec 31, 2016 | -6306.6% | +34615.4 |
| Q3 FY2016 | Sep 30, 2016 | -16203.9% | −8377.5 |
| Q2 FY2016 | Jun 30, 2016 | -4372.3% | +8511.7 |
| Q1 FY2016 | Mar 31, 2016 | -6727.5% | – |
| Q4 FY2015 | Dec 31, 2015 | -40922.0% | – |
| Q3 FY2015 | Sep 30, 2015 | -7826.4% | – |
| Q2 FY2015 | Jun 30, 2015 | -12883.9% | – |
See a number that looks wrong?